AI assistant
Adicet Bio, Inc. — Director's Dealing 2022
Nov 9, 2022
34412_dirs_2022-11-09_fe523d3e-8352-48d0-a0d9-e0e05b52e2c5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2022-11-07
Reporting Person: Schor Chen (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-11-07 | Common Stock | S | 30000 | $19.0496 | Disposed | 83424 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 101424 | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $19.00 to $19.24, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Securities and Exchange Commission staff upon request.
F3: Represents shares held directly by The C. Schor IRRV Trust, an irrevocable family trust having an independent trustee.